Korneuburg (pta/30.07.2021/18:00) - Marinomed Biotech AG hereby announces that due to the further exercise of stock options from the current employee stock option plan the total number of voting rights at the end of July 2021 has increased to 1,476,316 and the new stated capital amounts to EUR 1,476,316. The change of total voting rights has been effective since July 20, 2021.
Marinomed Biotech AG
|Contact Person:||Pascal Schmidt, CFO|
|Phone:||+43 2262 90300|
|Stock Exchange(s):||Official Trade in Vienna|